Watertown, MA, United States of America

Robert Christian Penland

USPTO Granted Patents = 2 

Average Co-Inventor Count = 17.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Robert Christian Penland: Innovator in S1P Receptor Modulating Compounds

Introduction

Robert Christian Penland is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of immunology through his innovative work on S1P receptor modulating compounds. With a total of 2 patents, Penland's inventions aim to address various autoimmune and related immune disorders.

Latest Patents

Penland's latest patents focus on compounds that act as S1P receptor modulating agents. These compounds are designed to treat diseases associated with inappropriate S1P receptor activity. The applications of these compounds include their use as immunomodulators for conditions such as systemic lupus erythematosus, inflammatory bowel diseases like Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis, myasthenia gravis, rheumatoid arthritis, and several other serious health issues.

Career Highlights

Robert Christian Penland is currently associated with Epix Pharmaceuticals, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of complex immune disorders.

Collaborations

Throughout his career, Penland has collaborated with esteemed colleagues such as Ashis K Saha and Nili Schutz. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Robert Christian Penland stands out as a significant figure in the field of immunology, with his innovative patents aimed at improving treatment options for autoimmune diseases. His contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…